Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.48
(
-0.17%
)
US TECH 100
26,364.00
(
0.24%
)
Dow Jones
48,836.35
(
-0.62%
)
Brent Oil
110.52
(
5.85%
)
Bitcoin
75,168.17
(
-1.54%
)
News Focus
News Focus
Post# of 257465
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

lgonber

Send PM Follow Ignore
Followers 12
Posts 648
Boards Moderated 0
Alias Born 12/20/2014

lgonber

Re: None

Friday, 04/28/2017 11:28:57 AM

Friday, April 28, 2017 11:28:57 AM

Post# of 257465
FDA approves RDUS osteoporosis drug
• Radius Health (RDUS +10.5%) heads north on a 4x surge in volume in response to the FDA's approval of TYMLOS (abaloparatide) injection for the treatment of postmenopausal women with osteoporosis at high risk of fracture.
• The company will host a webcast on Monday, May 1, at 7:30 am ET to discuss the approval.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today